Jiayi Huang

15PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Feb 26, 2026
Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial.

Jian L Campian, Son B Le, Ashley Ghiaseddin

|Aug 09, 2023
A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma.

Subhajit Ghosh, Tanner M Johanns, Milan G Chheda

|Jan 25, 2023
Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma.

Subhajit Ghosh, Jiayi Huang, Matthew Inkman

|Oct 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.

Christina I Tsien, Stephanie L Pugh, Adam P Dicker

|May 23, 2022
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.

Anna R Damato, Ruth G N Katumba, Jingqin Luo

Pageof 3

Frequent Collaborators

3 joint publications

Jian L Campian

3 joint publications

George Ansstas

2 joint publications

Milan G Chheda

2 joint publications

Omar H Butt